Tag Archives: COPD

Blood Eosinophilia-Targeted COPD Treatment: LABA-ICS vs LAMAs

December 06, 2018 Share this content: The incidence of pneumonia rose with initiation of LABA-ICS, which was similar across all eosinophil concentrations. Blood eosinophil concentrations could be used to target patients with chronic obstructive pulmonary disease (COPD) who are likely to respond to initial long-acting bronchodilator therapy. This, in turn, may help clinicians decide between… Read More »

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) Print this page DUBLIN, Ireland, HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) and Mylan N.V. (NASDAQ: MYL) (“Mylan”) today announced that the U.S. Food and Drug Administration (FDA) has approved the  New Drug Application (NDA) for… Read More »